McShane H - Search Results

1

Jacobs AJ, Mongkolsapaya J, Screaton GR, McShane H, Wilkinson RJ. Jacobs AJ, et al. Among authors: mcshane h. Tuberculosis (Edinb). 2016 Dec;101:102-113. doi: 10.1016/j.tube.2016.08.001. Epub 2016 Aug 26. Tuberculosis (Edinb). 2016. PMID: 27865379 Free PMC article. Review.

2

High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease.

Pathan AA, Wilkinson KA, Wilkinson RJ, Latif M, McShane H, Pasvol G, Hill AV, Lalvani A. Pathan AA, et al. Among authors: mcshane h. Eur J Immunol. 2000 Sep;30(9):2713-21. doi: 10.1002/1521-4141(200009)30:9<2713::AID-IMMU2713>3.0.CO;2-4. Eur J Immunol. 2000. PMID: 11009107 Free article.

3

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.

McShane H, Brookes R, Gilbert SC, Hill AV. McShane H, et al. Infect Immun. 2001 Feb;69(2):681-6. doi: 10.1128/IAI.69.2.681-686.2001. Infect Immun. 2001. PMID: 11159955 Free PMC article.

4

Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.

Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, Pasvol G, Hill AV. Lalvani A, et al. Among authors: mcshane h. Am J Respir Crit Care Med. 2001 Mar;163(4):824-8. doi: 10.1164/ajrccm.163.4.2009100. Am J Respir Crit Care Med. 2001. PMID: 11282752 Clinical Trial.

5

Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.

McShane H, Behboudi S, Goonetilleke N, Brookes R, Hill AV. McShane H, et al. Infect Immun. 2002 Mar;70(3):1623-6. doi: 10.1128/IAI.70.3.1623-1626.2002. Infect Immun. 2002. PMID: 11854254 Free PMC article.

6

Developing an improved vaccine against tuberculosis.

McShane H. McShane H. Expert Rev Vaccines. 2004 Jun;3(3):299-306. doi: 10.1586/14760584.3.3.299. Expert Rev Vaccines. 2004. PMID: 15176946 Review.

7

Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.

Williams A, Hatch GJ, Clark SO, Gooch KE, Hatch KA, Hall GA, Huygen K, Ottenhoff TH, Franken KL, Andersen P, Doherty TM, Kaufmann SH, Grode L, Seiler P, Martin C, Gicquel B, Cole ST, Brodin P, Pym AS, Dalemans W, Cohen J, Lobet Y, Goonetilleke N, McShane H, Hill A, Parish T, Smith D, Stoker NG, Lowrie DB, Källenius G, Svenson S, Pawlowski A, Blake K, Marsh PD. Williams A, et al. Among authors: mcshane h. Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):29-38. doi: 10.1016/j.tube.2004.09.009. Epub 2005 Jan 20. Tuberculosis (Edinb). 2005. PMID: 15687025

8

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.

McShane H, Pathan AA, Sander CR, Goonetilleke NP, Fletcher HA, Hill AV. McShane H, et al. Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):47-52. doi: 10.1016/j.tube.2004.09.015. Epub 2005 Jan 21. Tuberculosis (Edinb). 2005. PMID: 15687027 Review.

9

Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs.

Williams A, Goonetilleke NP, McShane H, Clark SO, Hatch G, Gilbert SC, Hill AV. Williams A, et al. Among authors: mcshane h. Infect Immun. 2005 Jun;73(6):3814-6. doi: 10.1128/IAI.73.6.3814-3816.2005. Infect Immun. 2005. PMID: 15908420 Free PMC article.

10

Tuberculosis vaccines: current status and future prospects.

Fletcher H, McShane H. Fletcher H, et al. Among authors: mcshane h. Expert Opin Emerg Drugs. 2006 May;11(2):207-15. doi: 10.1517/14728214.11.2.207. Expert Opin Emerg Drugs. 2006. PMID: 16634697 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page